In this modern-day, there is a myriad of ways for investors to turn their capital into profit easily. One of the ways is investing in stocks. There are a lot of opportunities in the stock market, but only a few present a promising and stable future.
One of the promising sectors is healthcare. Healthcare is one of the biggest and most dynamic industries, with a diverse variety of businesses selling medical goods and services. With medicine progressing at such a fast pace, there are a lot of ways to benefit from healthcare stocks. The healthcare sector has piqued investors’ interest since some of these companies have secured regulatory approval for drugs to treat COVID-19 and begun distributing vaccines, and others are racing to produce and gain approval for new COVID-19 drugs. Here are some of the most promising stocks to watch out for this year.
VXRT stock, also known as Vaxart, Inc., is a clinical-stage biotechnology corporation that develops and discovers oral recombinant protein vaccines using its patented oral vaccine platform. With its recent research into an oral vaccine for COVID-19, VXRT holds a lot of promise, especially since most patients would opt for a no-jab vaccine. Investors’ excitement about the company’s COVID-19 vaccine, VXA-CoV2-1, has boosted the price of its stock by 129.5 percent in the last year. With such promising statistics, coupled with its painless method of administration, VXRT is bound to rock the stock market this year and should be a constant on your radar.
Moderna is a biotechnology company focusing on the discovery and production of messenger RNA (mRNA) therapeutics and vaccines at the clinical level. Since gaining approval from the U.S. and other governments to supply millions of people with the COVID-19 vaccine in 2021, the company’s revenues have skyrocketed.
On April 19, Moderna announced that it had reached a new supply agreement with Israel for its COVID-19 vaccine for 2022. The new deal comes after two previous deals with Moderna to provide Israel with 10 million doses of the COVID-19 vaccine. The increasing number of contracts portrays a favorable future for its market price and big room for growth. Its stocks have shown an extraordinary performance over the years and continue to show a lot of promise for its future in the pharma industry. Due to its recent success in the battle against COVID 19, Pfizer is one of the top healthcare stocks that shouldn’t miss on your list of stocks to watch for this year.
Another crucial healthcare stock that every investor should keep an eye on is AbbVie. AbbVie owns the world’s most effective commercial drug, an immunosuppressant that treats a variety of conditions ranging from arthritis to plaque psoriasis, Crohn’s disease, and more. With shares worth over $190 billion, the company rose over 2.2% in the first quarter alone. ABBV stock pays a respectable 4.8 percent dividend, the highest on this list, and is also a dividend aristocrat, having increased its dividend payout for 49 consecutive years. AbbVie is the stock to buy if you want to beat the competition or increase your dividend income.
For investors looking to build a good investment portfolio on stocks, the addition of any of these three top healthcare stocks of 2021 will get you closer to your goal.